K. Fisher et Tj. Coderre, THE CONTRIBUTION OF METABOTROPIC GLUTAMATE RECEPTORS (MGLURS) TO FORMALIN-INDUCED NOCICEPTION, Pain, 68(2-3), 1996, pp. 255-263
The present study examined the role of mGluRs in nociceptive responses
of male Long-Evans rats following a subcutaneous (s.c.) injection of
1% (30 mu l) or 2.5% (50 mu l) formalin to the plantar surface of the
hindpaw. Intrathecal (i.t.) administration of the mGluR4/mGluR6-mGluR8
agonist, L(+)-2-amino-4-phosphonobutyric acid (L-AP4), the mGluR1/mGl
uR5 antagonists, (S)-4-carboxyphenylglycine ((S)-4CPG) or (S)-4-carbox
y-3-hydroxyphenylglycine ((S)-4C3HPG), but not the non-selective antag
onist, (+)-a-methyl-4-carboxyphenylglycine ((+)-MCPG), to the lumbar s
pinal cord slightly reduced second phase nociceptive responses. An i.t
. injection of the mGluR1/mGluR5 agonist, (RS)-3,5-dihydroxyphenylglyc
ine ((RS)-DHPG) or the mGlu2/mGluR3 agonist, (1S,3S)-1-aminocyclopenta
ne-1,3-dicarboxylic acid ((1S,3S)-ACPD), but not 'R,2'R,3'R)-2-(2'3'-d
icarboxy-cyclopropyl)-glycine (DCG-IV), dose-dependently enhanced form
alin-induced nociception in the second phase. In addition, the facilit
ation of nociceptive responses induced by (1S,3S)-ACPD or (RS)-DHPG wa
s reduced by prior i.t, administration of the mGluR antagonists, (+)-M
CPG or (S)-4C3HPG, respectively, as well as by the N-Methyl-D-aspartat
e (NMDA) receptor antagonist, D(-)-2-amino-5-phosphonopentanoic acid (
D-AP5). These results indicate that although mGluRs may play a minor r
ole in formalin-induced nociception, mGluR agonist-related facilitatio
n of formalin scores may reflect an interaction with the NMDA receptor
.